Genmab is forecast to grow earnings and revenue by 23.5% and 14.3% per annum respectively. EPS is expected to grow by 21.8% per annum. Return on equity is forecast to be 15.9% in 3 years.
Key information
23.5%
Earnings growth rate
21.8%
EPS growth rate
Biotechs earnings growth
39.3%
Revenue growth rate
14.3%
Future return on equity
15.9%
Analyst coverage
Good
Last updated
08 Nov 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:GE9 - Analysts future estimates and past financials data (DKK Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2026
28,852
7,976
7,819
8,293
17
12/31/2025
24,629
6,335
5,935
6,975
23
12/31/2024
21,274
5,522
5,084
5,911
19
9/30/2024
19,844
4,702
6,561
6,731
N/A
6/30/2024
19,016
5,540
6,515
6,735
N/A
3/31/2024
17,783
5,467
5,358
5,658
N/A
12/31/2023
16,474
4,352
7,004
7,380
N/A
9/30/2023
16,852
4,163
5,687
6,106
N/A
6/30/2023
16,227
4,641
5,634
6,037
N/A
3/31/2023
15,220
5,197
6,196
6,560
N/A
12/31/2022
14,505
5,452
3,595
3,912
N/A
9/30/2022
11,987
5,654
3,480
3,755
N/A
6/30/2022
10,210
3,962
1,964
2,234
N/A
3/31/2022
9,020
2,377
1,349
1,630
N/A
12/31/2021
8,417
2,957
1,976
2,228
N/A
9/30/2021
7,907
2,873
947
1,189
N/A
6/30/2021
7,321
2,513
5,609
5,820
N/A
3/31/2021
10,800
5,585
5,427
5,704
N/A
12/31/2020
10,111
4,758
6,126
6,433
N/A
9/30/2020
11,028
5,649
7,128
7,406
N/A
6/30/2020
10,344
5,656
2,369
2,647
N/A
3/31/2020
5,667
2,363
2,444
2,592
N/A
12/31/2019
5,366
2,166
1,215
1,326
N/A
9/30/2019
3,641
1,528
1,252
1,355
N/A
6/30/2019
3,199
1,170
782
1,248
N/A
3/31/2019
2,935
1,345
729
1,199
N/A
12/31/2018
3,025
1,472
537
1,015
N/A
9/30/2018
2,807
1,424
583
1,062
N/A
6/30/2018
2,532
1,239
N/A
892
N/A
3/31/2018
2,796
1,286
N/A
1,301
N/A
12/31/2017
2,365
1,104
N/A
1,589
N/A
9/30/2017
2,275
1,159
N/A
1,260
N/A
6/30/2017
2,316
1,354
N/A
1,422
N/A
3/31/2017
1,897
1,215
N/A
1,088
N/A
12/31/2016
1,816
1,187
N/A
328
N/A
9/30/2016
1,463
735
N/A
658
N/A
6/30/2016
1,376
686
N/A
591
N/A
3/31/2016
1,196
535
N/A
358
N/A
12/31/2015
1,133
764
N/A
311
N/A
9/30/2015
774
443
N/A
70
N/A
6/30/2015
768
463
N/A
23
N/A
3/31/2015
710
420
N/A
98
N/A
12/31/2014
850
301
N/A
133
N/A
9/30/2014
851
292
N/A
110
N/A
6/30/2014
729
138
N/A
-31
N/A
3/31/2014
751
138
N/A
-108
N/A
12/31/2013
664
70
N/A
-128
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GE9's forecast earnings growth (23.5% per year) is above the savings rate (1%).
Earnings vs Market: GE9's earnings (23.5% per year) are forecast to grow faster than the German market (20.5% per year).
High Growth Earnings: GE9's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GE9's revenue (14.3% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: GE9's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GE9's Return on Equity is forecast to be low in 3 years time (15.9%).